Join
Live feed
·
INSIDERFilingvia Quantisnow
eFFECTOR Therapeutics Inc. logo

Byrnes Michael was granted 4,524 shares, increasing direct ownership by 12% to 43,271 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
EFTR· eFFECTOR Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EFTR (eFFECTOR Therapeutics Inc.) and more on Quantisnow.